Securities code: 000756 securities abbreviation: Shandong Xinhua Pharmaceutical Company Limited(000756) Announcement No.: 2021-86 Shandong Xinhua Pharmaceutical Company Limited(000756)
Announcement on the reply to the notification letter on the preparations for the meeting of the issuance and Examination Committee of non-public offering of a shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Recently Shandong Xinhua Pharmaceutical Company Limited(000756) (hereinafter referred to as “the company”) received the letter on preparing for the meeting of Shandong Xinhua Pharmaceutical Company Limited(000756) non-public development bank stock issuance and Examination Committee (hereinafter referred to as “notification letter”) issued by China Securities Regulatory Commission (hereinafter referred to as “CSRC”). The company and relevant intermediaries have carefully checked and implemented the issues listed in the notification letter one by one in accordance with the requirements of the CSRC. Now, the reply to the notification letter is publicly disclosed in accordance with the relevant requirements. For the specific contents of the reply to the notification letter, see the company’s website cninfo.com.cn on the same day Reply to Shandong Xinhua Pharmaceutical Company Limited(000756) non public development bank A-share issuance and examination committee meeting preparation letter.
The company’s non-public offering of A-Shares needs to be approved by the CSRC. The company will timely disclose relevant information according to the progress of relevant matters, and investors are kindly requested to pay attention to investment risks.
It is hereby announced.
Shandong Xinhua Pharmaceutical Company Limited(000756) December 31, 2021
